Do systemic corticosteroids effectively treat obstructive sleep apnea secondary to adenotonsillar hypertrophy?

被引:50
作者
AlGhamdi, SA
Manoukian, JJ
Morielli, A
Oudjhane, K
Ducharme, FM
Brouillette, RT
机构
[1] MCGILL UNIV,MONTREAL CHILDRENS HOSP,DEPT PEDIAT,MONTREAL,PQ H3H 1P3,CANADA
[2] MCGILL UNIV,MONTREAL CHILDRENS HOSP,DEPT OTOLARYNGOL,MONTREAL,PQ H3H 1P3,CANADA
[3] MCGILL UNIV,MONTREAL CHILDRENS HOSP,DEPT RESP THERAPY,MONTREAL,PQ H3H 1P3,CANADA
[4] MCGILL UNIV,MONTREAL CHILDRENS HOSP,DEPT RADIOL,MONTREAL,PQ H3H 1P3,CANADA
关键词
D O I
10.1097/00005537-199710000-00017
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
To determine if pediatric obstructive sleep apnea syndrome (OSAS) caused by adenotonsillar hypertrophy (ATH) could be treated by a short course of systemic corticosteroids, we conducted an open-label pilot study in which standardized assessments of symptomatology, OSAS severity, and adenotonsillar size were performed before and after a 5-day course of oral prednisone, 1.1 +/- 0.1 (+/- SE) mg/kg per day. Outcome measures included symptom severity, adenotonsillar size, and polysomnographic measures of OSAS. Selection criteria included age from 1 to 12 years, ATH, symptomatology suggesting OSAS, an apnea/hypopnea index (AHL) greater than or equal to 3/hour, and intent to perform adenotonsillectomy. Only one of nine children showed enough improvement to avoid adenotonsillectomy, Symptomatology did not improve after corticosteroid. treatment but did after removal of tonsils and adenoids, Polysomnographic indices of OSAS severity did not improve after corticosteroid treatment. After corticosteroids, tonsillar size decreased in only two patients, adenoidal size was only marginally reduced, and the size of the nasopharyngeal airway was not significantly increased, These results suggest that a short course of prednisone is ineffective in treating pediatric OSAS caused by ATH.
引用
收藏
页码:1382 / 1387
页数:6
相关论文
共 39 条
[1]   EFFICACY AND SAFETY OF INHALED CORTICOSTEROIDS IN ASTHMA - REPORT OF A WORKSHOP HELD IN EZE, FRANCE, OCTOBER 1992 [J].
BARNES, PJ ;
PEDERSEN, S .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 148 (04) :S1-S26
[2]   MEDICAL-MANAGEMENT OF CHRONIC MIDDLE-EAR EFFUSION - RESULTS OF A CLINICAL-TRIAL OF PREDNISONE COMBINED WITH SULFAMETHOXAZOLE AND TRIMETHOPRIM [J].
BERMAN, S ;
GROSE, K ;
ZERBE, GO .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1987, 141 (06) :690-694
[3]  
BRODSKY L, 1993, ARCH OTOLARYNGOL, V119, P821
[4]  
BRODSKY L, 1988, LARYNGOSCOPE, V98, P93
[5]  
BRODSKY L, 1988, LARYNGOSCOPE, V98, P1055
[6]  
BRODSKY L, 1969, PEDIATR CLIN N AM, V36, P1551
[7]   COMPARISON OF THE MICROBIOLOGY OF GROUP-A AND NON-GROUP-A STREPTOCOCCAL TONSILLITIS [J].
BROOK, I ;
YOCUM, P .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1988, 97 (03) :243-246
[8]   A DIAGNOSTIC-APPROACH TO SUSPECTED OBSTRUCTIVE SLEEP-APNEA IN CHILDREN [J].
BROUILETTE, R ;
HANSON, D ;
DAVID, R ;
KLEMKA, L ;
SZATKOWSKI, A ;
FERNBACH, S ;
HUNT, C .
JOURNAL OF PEDIATRICS, 1984, 105 (01) :10-14
[9]  
Brouillette RT, 1996, AM J RESP CRIT CARE, V153, P1
[10]   OBSTRUCTIVE SLEEP-APNEA IN INFANTS AND CHILDREN [J].
BROUILLETTE, RT ;
FERNBACH, SK ;
HUNT, CE .
JOURNAL OF PEDIATRICS, 1982, 100 (01) :31-40